Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Update

Genscript Biotech Co. (OTCMKTS:GNNSF) was the target of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 4,198,000 shares, an increase of 71.7% from the July 30th total of 2,444,582 shares. Based on an average daily trading volume, of 3,300 shares, the short-interest ratio is currently 1,272.1 days.

Genscript Biotech Price Performance

Shares of GNNSF stock traded down C$0.15 on Monday, hitting C$4.35. The stock had a trading volume of 2,597 shares, compared to its average volume of 4,686. Genscript Biotech has a 1 year low of C$1.30 and a 1 year high of C$5.00. The company’s 50 day moving average price is C$2.34 and its 200-day moving average price is C$1.84.

About Genscript Biotech

GenScript Biotech Corporation is a global contract research, development and manufacturing organization (CDMO) specializing in synthetic biology and biopharmaceutical services. Founded in 2002, the company provides end-to-end solutions that span gene and peptide synthesis, recombinant protein expression, custom antibody discovery and cell line development. GenScript’s integrated platforms support early-stage discovery through to process development, enabling academic institutions, biotech innovators and pharmaceutical companies to accelerate research timelines.

The company’s core offerings include molecular biology services such as DNA construction, gene editing using CRISPR/Cas9 technology and high-throughput peptide libraries.